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PREFACE 
This study is concerned with the ability of ivermectin (MK-933) to 
eliminate patent infections of Parelaphostrongylus tenuis in white-
tailed deer (Odocoileus virginianus) and to prevent development of 
infection by.!:· tenuis in white-tailed deer and in fallow deer (Dama 
dama). Fallow deer were chosen in this study to represent 
neurologically susceptible cervids. 
A few limitations were encountered in designing this study. The 
number of animals were limited to a portion of the annual supply of 
white-tailed deer fawns born in the Deer Disease Research facility or 
brought to it by the Oklahoma Department of Wildlife Conservation. 
Fallow deer were chosen for their ease of availability, smaller size, 
relative ease of handling, and cost compared to elk or other large 
cervids that are known to be neurologically susceptible to the 
parasite. All animals were given a reasonable amount of space, food, 
water and veterinary medical care; even so, there were unexplained 
deaths, a common occurren,ce among captive wild animals used for 
research purposes. 
Histopathologic examination was used for verification of 
infections and was limited to cellular reaction to eggs and larvae in 
the lungs or to adults on the meninges. Dr. D. Whitnack assisted in 
these interpretations. 
The author expresses appreciation to his major advisor, Dr. A. 
Alan Kocan, for his guidance and assistance throughout this study. 
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recommendations. 
A note of thanks is given to Dr. K. H. Olsen for his assistance 
and editing. Thanks are also extended to Judy Tyson for her superb 
typing. 
In addition, appreciation is extended to the Oklahoma Department 
of Wildlife Conservation for the facilities and supply of research 
animals and to the Merck, Sharp and Dohme Research Laboratories, 
Rahway, New Jersey, for the drug used in this study. This study was 
supported in part by the Oklahoma State University College of 
Veterinary Medicine and the Oklahoma Department of Wildlife 
Conservation, Federal Aid in Wildlife Restoration Act, Pittman 
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The meningeal worm Parelaphostrongylus tenuis ( = Pneumostrongylus 
tenuis Dougherty 1945) is a parasite of white-tailed deer in eastern 
North America (Prestwood and Smith 1969). Although this parasite 
seldom produces clinical signs in white-tailed deer, natural infections 
of P. tenuis in the following cervids typically result in neurologic 
disease: moose (Alces alces) (Anderson 1965), caribou (Rangifer 
tarandus terraenovae) (Behrend and Witter 1968), reindeer (Rangifer 
tarandus tarandus) (Anderson 1971), wapiti (Cervus canadensis) 
(Carpenter et al. 1973), black-tailed deer (Odocoileus hemionus 
columbianus) (Nettles et al. 1977a) and fallow deer (Dama dama) 
(Kistner et al. 1977 and Nettles et al. 1977b). The clinical signs 
usually seen in these animals consist of circling, often associated 
with blindness, nystagmus and holding of the neck in abnormal positions 
and ataxia, stiffness and posterior weakness that often develops into 
paraplegia. The parasite appears to be endemic in the eastern part of 
North America and restricted to physiographic regions where 
white-tailed deer and the intermediate hosts, certain species of 
terrestrial gastropods, exist (Prestwood and Smith 1969 and Kocan 
et a 1. 1982). 
This disease has been a concern for wildlife workers for many 
years. Problems arise when infected animals move or are transported to 
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areas nonendemic for P. tenuis. This may establish infections in 
susceptible animals not previously exposed to meningeal worm if the 
proper intermediate hosts are present. Also, non-infected and 
susceptible animals may become infected when they move or are 
transported into areas where P. tenuis is endemic. Tiiese two factors 
are important for state relocation programs and for the increasing 
number of drive-through game parks. Introduction of infected 
white-tailed deer into a susceptible cervid population may have as 
disastrous results as moving a susceptible population to an area where 
P. tenuis is endemic. A drug capable of prevention of infection or 
elimination of P. tenuis from infected animals would be a valuable tool 
for preparing exposed animals destined to be moved into non-endemic 
areas or for preventing infection in susceptible animals exposed to the 
parasite. The drug ivermectin, the 22, 23-dihydroavermectin B1 
derivative of avermectin, has been proven to be an effective 
anthelmintic against many parasites of sheep, cattle, horses and dogs 
(Campbell 1981, Egerton et al. 1981, Herd et al. 1981 and Campbell and 
Blair 1978, Blair and Campbell 1978, 1979 and 1980). This study is 
designed to test this new drug's ability to eliminate and to prevent 
infection of P. tenuis in white-tailed deer and to prevent infection in 
fallow deer, the latter chosen in this study to represent 




The meningeal worm Parelaphostrongylus tenuis inhabits the cranial 
subdura 1 space, crania 1 venous sinuses, and the spina 1 subdura 1 space 
of white-tailed deer (Odocoileus virginianus). Except in heavy 
infections this parasite rarely causes neurologic disorders in 
white-tailed deer (Prestwood 1970). Verminous neurologic disease, the 
clinical signs manifested from damage to the neural parenchyma of the 
spinal cord or brain by larval or adult worms, has been reported in 
caribou (Rangifer tarandus terraenovae) (Behrend and Witter 1968), 
moose (Alces alces) (Anderson 1965), reindeer (Rangifer tarandus 
tarandus) (Anderson 1971), wapiti (Cervus canadensis) (Carpenter et al. 
1973), black-tailed deer (Odocoileus hemionus columbianus) (Nettles et 
al. 1977a) and fallow deer (Dama dama) (Kistner et al. 1977 and Nettles ----
et al. 1977b). Neurologic disease resulting from experimental 
infections with the meningeal worm has been produced in caribou 
(Anderson and Strelive 1968), moose (Anderson 1964), mule deer 
(Odocoileus hemionus hemionus) (Tyler et al. 1980), wapiti (Anderson et 
al. 1966), and domestic goa-ts (Capra hircus) (Anderson and Stre live 
1969). 
In white-tailed deer, adult worms lay eggs on the meninges or in 
the circulatory system. These eggs are carried to the lungs by the 
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blood where emboli develop around them. The eggs embryonate and the 
larvae break out into the alveoli, pass up the respiratory tract, are 
swallowed, and pass from the host in the feces (Anderson and Davis 
19 71) • 
Once in the environment the larvae penetrate slugs and snails. 
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Various species of terrestrial gastropods have been experimentally 
infected, but those of the species Deroceras laeve and Zoinitoides 
nitidus are probably the most important in transmission of P. tenuis in 
the wild (Lankaster and Anderson 1968). Other species, Triodopsis 
albolabris and Mesodon thyroidus, also serve as effective intermediate 
hosts. Development of!'._. tenuis larvae to the infective stage requires 
at least three weeks at 25°C (Anderson 1963) and probably longer at 
lower temperatures. The number of larvae contained in naturally 
infected gastropods is usually only four or five per individual 
(Lancaster and Anderson 1968). Deer and other cervids are infected by 
accidentally ingesting gastropods containing infective P. tenuis 
larvae. The larvae are released from the gastropod tissues in the 
abomasum of the deer by action of digestive juices and then penetrate 
the ventral curvature of the abomasum, enter the peritoneal cavity and 
reach the spinal cord in about ten days (Anderson and Strelive 1967). 
The worms develop in the dorsal horns of the spinal cord in twenty to 
thirty days from after they migrate through the dorsal nerve roots into 
the subdural space where they reach sexual maturity. The prepatent 
period is from eighty-two to ninety-one days (Anderson and Davis 1971). 
Except with heavy infections, white-tailed deer, the meningeal 
worm's probable natural hosts, normally do not manifest the typical 
clinical signs of meningeal worm infections seen in abnormal hosts 
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which consist of circling, often associated with blindness, nystagmus, 
and holding of the neck in abnormal positions; ataxia, stiffness and 
posterior weakness that often develops into paraplegia. Anderson and 
Strelive (1967) noted that the recovery of adult worms from the central 
nervous system in white-tailed deer is noticeably less than the number 
of larvae given them. This is in contrast to the case in moose and 
wapiti where an unusually high percentage of the larvae ingested reach 
the nervous system (Anderson 1964 and Andersonvet al. 1966). It is 
thought that these hosts are unable to activate their defense 
mechanisms as rapidly or as effectively as white-tailed deer, thus 
allowing a greater percentage of larvae to survive the migration to the 
central nervous system (Anderson and Strelive 1967). This 
susceptibility to neural invasion accounts for only part of the 
severity of clinical signs seen in moose, wapiti, caribou, reindeer, 
fallow deer, mule deer, black-tailed deer and domestic sheep and 
goats. There is evidence that damage in these animals is due to 
P. tenuis larvae which consists of extensive trauma to the spinal cord 
(Anderson 1964). In contrast, it is suggested the neurologic signs 
seen in heavily infected white-tailed deer is not due to trauma to the 
neural parenchyma from wandering~· tenuis larvae, but to large masses 
of adult worms in the venous sinuses and the reaction they provoke by 
mechanically interfering with blood flow (Prestwood 1970). 
Histologically, lesions in the dura mater of heavily infected 
white-tailed deer consist of thickenings of the dura mater, focal 
accumulation of lymphocytes and numerous eosinophils. Commonly, eggs 
and larvae are found surrounded by connective material and giant 
cells. Prestwood (1970) found pigment in the meninges and cerebral 
cortex. This strong cellular response is in contrast to the cellular 
response in animals that show clinical signs from P. tenuis. For 
example, in black-tailed deer, occurrence of aggregates of eosinophils 
in the spinal cord is common (Nettles et al. 1977), while in mule deer 
eosinophils are occasionally found with lymphocytes and plasma cells. 
In wapiti, histological lesions consisted of lymphocyte infiltration 
interspersed with a few macrophages, eosinophils, and sometimes 
rnultinucleated giant cells which indicate a weaker cellular response 
than shown by white-tailed deer. Kistner et al. (1977) noted that in 
fallow deer histological lesions were characterized by marked 
thickening and chronic inflammation of the dura mater, subdural 
hemorrhage, marked lymphocyte infiltration and mineralization. No 
eosinophils were seen. This also contrasts with the reaction seen in 
the white-tailed deer. 
The Drug 
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Chabala et al. (1980) states that ivermectin is the 
22 1 23-dihydroaverrnectin B1 derivative of avermectin: a rnacrocyclic 
lactone produced by a species of actinomycete, Streptomyces 
averrnitilis. The averrnectins are especially effective when given 
orally or parenterally against many immature and mature nematode and 
arthropod parasites of sheep (Campbell 1981, Wescott and Leamaster 
1982), cattle (Egerton et a 1. 1981, Nolan et a 1. 1981), dogs (Campbe 11 
and Blair 1978, Blair and Campbell 1980), horses (Donham 1981, Herd, 
Yazwinski 198la, and Yazwinski 198lb,) and swine (Barth et al. 1980). 
The avermectins paralyze worms, but in a different manner than 
some of the more common anthelmintics, (organophosphates, bephenium, 
thenium, pyrantel piperazine and levamisole). 
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The organophophates paralyze by inhibiting the acety lecho 1-
inesterase needed for deactivation of choline, bephium and thenium by 
mimicing choline by binding to its recepters, pyrantel by depolarizing 
the cell membranes, piperazine by hyperpolarizing the cell membranes 
and levamisole by stimulating the nerve ganglion directly (Campbell 
1981). In nematodes the neurotransmitter involved with sending 
inhibitory signals from the interneurons to the motor neurons is gamma-
arninobutyric acid, or GABA. The avermectins act as GABA agonists 
(Campbell 1981). They potentiate the GABA effect at the synapse. It 
is believed that this is done by stimulating the pre-synaptic release 
of GABA and enhancing its binding to the post-synaptic receptors. This 
inhibitory neurotransmitter functions to open the chloride channels on 
the postsynaptic side allowing chloride ions to flow in and induce the 
"resting" condition. The excitatory neurotransmitter, acetylcholine in 
the case of nematodes, triggers the influx of sodium ions into the 
motor-neuron. In the presence of avermectins, the chloride channels 
are open when they should be shut; chloride ions flow even when only 
sodium should be entering. Thus the motor-neuron remains negatively 
charged and signals are not registered by the recipient cell. The 
motor-neuron and muscle cell retain their capacity for action but do 
not receive the signal and thus the muscle cell does not function. 
Ivermectin has been shown to be effective as an anthelmintic. 
Egerton et al. (1979) reported that dosages of .05 and 0.1 mg/kg 
produced a ninety-six to ninety-nine percent reduction in worm burdens 
of Haemonchus contortus, Trichostrongylus axei, !· colubriformis and 
Oesophagostomum columbianum in sheep. Similar results were seen in the 
case of cattle (Egerton et al. 1980, Egerton et al. 1981). Even at low 
dosages (0.025 mg/kg) there was nearly one-hundred percent activity 
against Dictyocaulus viviparus and Oesophagostomum. At dosages of 0.2 
mg/kg ivermectin was highly effective against seven species of gastro-
intestinal parasites, as well as lungworm. Ivermectin has even been 
noted to show strength against inhibited fourth stage larvae, drug-
resistant strains and lungworm. 
Blair and Campbell (1980) showed that ivermectin was effective 
with an oral dosage of 0.05 mg/kg in preventing heartworm in dogs by 
acting against the microfilaria. This dosage level did not affect the 
adult heartworm, a desirable feature in animals with patent 
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infections. Ivermectin is highly effective against Ancylostoma caninum 
at the same dosage (Blair and Campbell 1978). 
Two papers by Yazwinski et al. (198la and 198lb) demonstrated 
ninety-seven percent to one-hundred percent efficacy of ivermectin 
against mature and immature Parascaris equorum and Oxyuris equi, 
respectively, at a dosage of 0.2 mg/kg. 
In most work with gastrointestinal parasites ivermectin was given 
orally (Blair and Campbell 1978, Blair and Campbell 1979 and 1980). In 
horses researchers gave ivermectin I.M. in the neck for both gastro-
intenstinal parasites and larvae of Draschia and Habronema. In sheep, 
ivermectin has been administered subcutaneously (Westcott and Leamaster 
1982) and good results were seen against most gastrointestinal para-
sites including Dictyocaulus, a lungworm. Oral dosages ranged from 100 
mg/kg to 0.1 mg/kg. Intramuscular and subcutaneous doses were much 
smaller, ranging from 0.2 mg/kg to 0.01 mg/kg, with good results 
throughout the range. Even with the high dosages, signs of drug 
toxicity were not seen (Blair and Campbell 1979). 
CHAPTER III 
MATERIALS AND METHODS 
Gastropods of the species Triodopsis albolabris were kept at room 
temperature in terrariums containing vermiculite and were given lettuce 
ad libitum. Snails were infected with P. tenuis larvae by exposing 
them to feces from experimentally infected white-tailed deer. After a 
three week development period for the larvae, the snails were cut with 
scissors and placed in a solution of one percent pepsin and one percent 
hydrochloric acid and allowed to digest for one hour to collect 
infective third stage larvae. The larvae were then counted and the 
inoculum standardized. 
The white-tailed deer used in this experiment were kept at the 
Deer Disease Research facility near Lake Carl Blackwell, Payne County, 
Oklahoma. The Oklahoma State University College of Veterinary Medicine 
maintains this ten acre facility in conjunction with the Oklahoma 
Department of Wildlife Conservation. All deer were caught by hand or 
immobilized with succinylcholine chloride and exposed to seventy-five 
larvae by passing a small tube down the esophagus into the rumen and 
administering the larvae with a syringe. 
All deer were parasite free before the experiment. All larvae 
found in feces and eggs and larvae found in the lungs by histologic 
examination were therefore identified as P. tunuis. Identification of 




Group I consisted of six white-tailed deer with patent infections. 
Four deer had ten-month-old infections and two had five-month-old 
infections. Three of the first four (ten-month-old infections) were 
given 0.20 mg/kg of ivermectin subcutaneously, and one of the latter 
two (five-month-old infections) was given 0.40 mg/kg, also subcutane-
ously. Twenty grams of feces were examined every other day starting 
twenty to sixteen days before treatment and continued until larval 
counts reached zero or until approximately sixty days post-treatment. 
These fecal samples were placed in a Baermann apparatus with 500 ml of 
warm water and allowed to set for twenty-four hours. Thirty ml of 
fluid was drawn from the apparatus and examined 10 ml at a time in a 
gridded petri dish under a dissecting microscope for the presence of 
larvae. The number of larvae was counted and totaled for each sample. 
All animals were euthanitized and removed to the necropsy facilities. 
At necropsy all deer were examined for the presence of P. tenuis adults 
in the cranial spaces by removing the skull cap and brain, incising and 
reflecting the dura mater, and observing for the thread-like worms on 
the meninges. The meninges were observed for petechial hemorrhages, 
granulation, or any other change in normal tissue. Samples of lung 
tissue were taken and sectioned histologically to observe eggs and 
tissue reaction. Additionally, liver, spleen and other tissues were 
preserved in ten percent formalin for future reference. 
Group II 
Group II consisted of four white-tailed deer. These deer were 
exposed to infective larvae as previously described. Twenty-four hours 
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after exposure to seventy-five larvae three deer were given 0.20 mg/kg 
of ivermectin subcutaneously. The fourth deer was given seventy-five 
larvae, but did not receive the invermectin treatment. Beginning day 
ninety post-treatment, fecal samples were taken every other day, placed 
in a Baermann apparatus, left for 24 hours, and then 30 ml of water was 
drawn and examined for larvae. The deer were necropsied at day 
one-hundred nineteen after exposure and the cranial and spinal spaces 
were observed for the presence of adult P. tenuis as well as for 
petechial hermorrhages, granulation or other lesions. Additionally, 
liver, spleen and lung tissues were preserved in ten percent formalin 
for future reference. 
Group III 
Group III consisted of two fallow deer and one white-tailed deer. 
All three deer were exposed to seventy-five larvae as in Group I. 
Twenty-four hours after exposure to the larvae one fallow was treated 
with 0.20 mg/kg of ivermectin. Eight hours later the untreated fallow 
deer died of unknown causes, but the treated fallow was kept and 
observed for neurologic signs. Fecal samples were examined after day 
ninety post-exposure on the white-tailed deer to determine the 
viability of the larvae. 
The ivermectin (MK-933) used in this experiment was obtained from 
the Merck, Sharp and Dahme Research Labororatories, Rahway, New 





Group I. The number of larvae observed in the feces from treated 
white-tailed deer #507 (0.2 mg/kg) dropped to zero eighteen days after 
treatment. At thirty days post-treatment the number of larvae observed 
increased to twenty-three, but by day thirty-five post-treatment counts 
dropped to zero again (Table I). At necropsy, two live male!'...· tenuis 
adults were found on the meninges. The meninges revealed large amounts 
of granulation, petechial hemorrhages, and a mucus coat covered a large 
percentage of the meninges. Histologically, the meninges revealed 
multiple foci of lymphocytes, increased connective tissue and 
granulation. Lung tissue revealed chronic pleuritis and multifocal 
parasite granulomas with eggs present in some of these, however, 
without visible larvae. 
The number of larvae observed from treated white-tailed deer #508 
(0.2 mg/kg) dropped to zero twenty days after treatment, increased to 
one and two larvae total on days twenty-six and thirty, respectively, 
and dropped to zero again (Table I). Upon necropsy five (three alive). 
male P. tenuis adults were found on the meninges. The meninges 
revealed slight petechial hemorrhage, some granulation, and some 
mucus. Histologically, lung tissue revealed multiple foci of 
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lymphocytes and hemosiderin-laden focal macrophages, but no eggs or 
larvae were seen. 
The number of larvae observed from treated white-tailed deer #511 
(0.2 mg/kg) dropped to zero by day twenty-one post-treatment, but a 
moderately high count of sixteen at forty-three days post-treatment, 
was observed the day before necropsy (Table I). At necropsy no adults 
were found on the meninges. The meninges were pearly-white with small 
petechial hemorrhages and granulomas. Histologically, lung tissue 
revealed multiple parasite lesions. Eggs were present in some of the 
lesions and larvae were observed in some lesions. 
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The number of larvae observed from treated white-tailed deer #503 
(0.4 mg/kg) dropped to zero on day seventeen post-treatment no others 
were recovered (Table II). One male and one female P. tenuis were 
found on the meninges at necropsy. The meninges were thickened and 
contained foci of lymphocytes and macrophages. They had small 
granulations and minor petechial hemorrhages. No excess mucus was 
seen. Histologically, lung tissue revealed chronic pleuritis and small 
gran~lomas. Very few larvae and no eggs were observed in the 
granulomas. 
White-tailed deer #516 was an untreated control. The number of 
larvae observed dropped to zero at day twenty-four post-treatment. 
Larval counts rose six days later and were increasing above seventy the 
day of necropsy (Table I). Two live male P. tenuis adults were 
observed on the meninges at necropsy. The meninges revealed no 
granulation or petechial hemorrhages. Histologically, lung tissue 
showed numerous parasite nodules, a large number of which contained 




THE NUMBER OF LARVAE OBSERVED IN 20 GRAM FECAL SAMPLES 
FROM TREATED AND UNTREATED WlUTE-TAILED DEER 
WITH TEN-MONTH-OLD PATENT INFECTIONS OF 
PARELAPHOSTRONGYLUS TENUIS 
TREATED WITH 0 .2 M;/KG OF 
IVERMECTIN SUBCUTANEOUSLY 
NUMBER OF LARVAE OBSERVED 
Day Post- Treated Treated Treated Untreated 
Treatment 1!507 11508 1!511 :/!516 
-20 5 3 7 22 
-18 101 24 0 0 
-16 8 18 407 12 7 
-14 24 23 7 7 
-12 51 48 2280 695 
-10 49 94 262 517 
-8 69 222 255 1522 
-6 393 112 67 218 
0 
+l 6 22 149 
+3 54 1687 1121 10 
+5 1127 1917 788 
+7 1149 604 615 
+9 452 125 39 174 
+14 109 76 9 340 
+16 5 7 27 19 
+18 0 7 50 4 
+20 0 0 14 1 
+21 0 0 0 2 
+24 0 0 0 0 
+26 0 1 0 0 
+30 23 2 0 0 
+32 7 0 0 1 
+35 0 0 0 32 
+37 0 0 0 13 
+43 0 0 16 70 
TABLE II 
THE NUMBER OF LARVAE OBSERVED IN 20 GRAM FECAL SAMPLES 
FROM TREATED AND UNTREATED WHITE-TAILED DEER 
WITH FIVE-MONTH-OLD PATENT INFECTIONS OF 
PARELAPHOSTRONGYLUS TENUIS 
TREATED WITH 0 .4 M; /KG OF 
IVERMECTIN SUBCUTANEOUSLY 
NUMBER OF LARVAE OBSERVED 
Day Post- Treated Untreated 
Treatment 1t503 11502 
-16 184 2148 
-14 105 
-12 11 3092 
-10 63 1809 
-8 15 
-6 42 218 
-4 70 97 
-2 88 368 
0 
+2 282 191 
+5 383 168 
+7 43 114 
+9 2 105 
+11 38 102 
+ 13 6 107 
+ 15 2 61 
+ 17 0 57 
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White-tailed deer #502 was also an untreated control. The number 
of larvae observed never dropped below fifty (Table II). At necropsy 
six live male and four live female P. tenuis adults were found on the 
meninges. Grossly, the meninges revealed large amounts of mucus and 
large petechia 1 hemorrhages. His to logically, the meninges were 
thickened and had foci of lymphocytic nodules and macrophages 
containing hemosiderin. There were numerous parasitic granulomas in 
the section of lung: these consisted of parasite eggs or larvae in the 
granulomas surrounded by a zone of macrophages and multinucleated 
cells. Eggs were more numerous than larvae. 
Group II 
The one untreated white-tailed deer contra l was observed to have 
larvae present in its feces one-hundred seventeen days after exposure 
to seventy-five infective larvae. At one-hundred nineteen days after 
exposure this animal, along with the other three from this group, was 
necrops ied; two live female and four live ma le adult P. tenuis were 
observed on the meninges. Grossly, the meninges had small petechial 
hemorrhages and had no granulation. Histologically, lung tissue 
revealed parasite granulomas with eggs and larvae within. The three 
treated white-tailed deer had pearly-white meninges and no adult 
P. tenuis were observed there. Lung tissue from each of these animals 
revealed normal tissue void of parasite lesions. 
Group III 
The one exposed, untreated fallow deer died from unrelated causes 
two days after exposure to infective larvae. The exposed, treated 
16 
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fallow deer revealed no changes in behavior, or posture. No clinical 
signs were observed in this animal up to two months after exposure to 
larvae. The white-tailed deer used to test viability of the larvae was 
necropsied ninety-seven days after exposure to infective larvae, even 
though first stage larvae had not been observed in its feces. Two live 
male and one live female were found on the meninges. 
CHAPTER V 
DISCUSSION 
The effect of ivermectin on patent infections of Parelaphostrongylus 
tenuis shows several things. First, there seems to be a large increase 
in the number of larvae observed starting soon after treatment and 
lasting for up to ten days (Tables I and II). No such increase in 
larval counts was observed in untreated control deer (Tables I and 
II). Because this occurs so soon after treatment it can be suggested 
that the drug affects the larvae present in the lungs and allows them 
to be swept from the lungs in greater quantities by ciliary action than 
if they were mobile. However, since the larvae observed in the feces 
were moving this phenomenon may just be normal variation in larvae 
found in fecal samples. Secondly, counts show that the number of 
larvae observed in the feces drops to zero seventeen to twenty-one days 
post-treatment. It is doubtful, because of the blood-brain barrier, 
that the adults were affected by either dosage of the drug and so an 
explanation of the dropping larval counts must come from the effect of 
the drug on larvae traveling in the bloodstream or residing in the 
tissues of the lungs. This is supported by the fact that in some 
animals, especially #511 and #516, larvae were again observed after a 
period of absence, indicating that adults were not affected and 
continued to produce eggs and larvae. Thirdly, the effects of 
ivermectin seems to last only for a month or a little more at a dosage 
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level of 0.2 mg/kg. Larval counts on animal ~fo511 (Table I) were 
increasing at the time of necropsy. This is also supported by a paper 
by Blair and Campbell (1979) in which they report suppression of 
circulating larvae (microfilaria) of Dirofilaria immitis soon after 
treatment with ivermectin but normal levels of microfilaria returned as 
soon as nine weeks post-treatment. Histologic lung sections also 
support the fact that ivermectin lasts only a month or a little more. 
Along with older granulomas there is evidence of new invasions of 
viable eggs and larvae in treated animals. Lung tissue in untreated 
animals had the usual progression of old granulomas, older granulomas 
with eggs and larvae, and new invasions of eggs and larvae. 
At the dosages given here (0.2 mg/kg and 0.4 mg/kg) there seems to 
be no appreciable affect on adult P. tenuis. It may be that this is 
due to the blood-brain barrier or it may be that ivermectin does not 
affect P. tenuis adults as was also the case with Dirofilaria adults no 
matter how high the dosage (Blair and Campbell 1979) • 
. There was no significant difference in the number of adult 
P. t_enuis between treated and untreated animals. 
The condition of the meninges of treated animals seems no worse 
than that of untreated animals. This response: granulation, petechial 
hemorrhage, presence of mucus, may be due to dead worms. However, the 
difference is not extreme enough to infer that this difference is 
significant. In fact, one treated animal, #511, had normal meninges 
and no adults were seen even though larvae were seen in the feces. 
The higher dosage of 0.4 mg/kg seems to have no advantage over the 
lower dosage of 0.2 mg/kg. It did not seem to influence the length of 
time before the number of larvae observed drops to zero. The large 
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increase in larval counts soon after treatment still occurs (Table II), 
but the peak is not as high as with the lower dosage. 
The effect of ivermectin on newly acquired Parelaphostrongylus 
tenuis infections is distinct. The treated white-tailed deer failed to 
develop patent infections, have larvae present in their feces, or have 
parasite lesions, eggs, or larvae in the lung tissues. The untreated 
control animal developed a patent infection: larvae present in its 
feces and adult worms on the meninges. 
Because the exposed, untreated fallow deer (control) died of 
unrelated causes, the effects of ivermectin in preventing P. tenuis 
infections in fallow deer cannot be proved from the results of this 
experiment. However, the literature states that fallow deer are 
susceptible and develop neurologic disease (Kistner et al. 1977 and 
Nettles et al. 1977b) and the larvae given to the treated fallow deer 
were proved to be viable because infection developed in the 
white-tailed deer control. Thus, it can be concluded from this and 
from the failure of the treated fallow deer to develop neurologic 
disease that ivermectin was effective at preventing infection, as it 
was 1n the white-tailed deer from Group II. 
CHAPTER VI 
SUMMARY 
The efficacy of ivermectin on patent infections of ~· tenuis in 
white-tailed deer is: (1) at the dosages given (0.2 mg/kg and 0.4 
mg/kg) adults residing on the meninges were not affected; (2) the 
number of larvae observed in the feces drops to zero between sixteen 
and twenty-one days post-treatment but larvae are again seen in the 
feces after a short period of absence; and (3) ivermectin apparently 
lasts no more than a month-and-a-half in the body (possibly longer at 
higher dosages than those given here) (Blair and Campbell 1979). More 
research is needed to determine if higher dosages will completely 
eliminate the infection. 
Ivermectin is effective in preventing infection of P. tenuis in 
both white-tailed deer and in fallow deer. It is recommended that more 
research be done with ivermectin in other cervids. It is also sug-
gested that if this drug is to be used prophylactically that treatment 
would have to be done on a monthly basis if the animals were constantly 
exposed to infective larvae. 
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